| ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer P Iyer, SV Shrikhande, M Ranjan, A Joshi, N Gardi, R Prasad, ... International journal of cancer 144 (8), 2008-2019, 2019 | 44 | 2019 |
| Drug-sensitiveFGFR3 mutations in lung adenocarcinoma P Chandrani, K Prabhash, R Prasad, V Sethunath, M Ranjan, P Iyer, ... Annals of oncology 28 (3), 597-603, 2017 | 42 | 2017 |
| Acellular dermis as a dermal matrix of tissue engineered skin substitute for burns treatment AK Shukla, N Dey, P Nandi, M Ranjan Ann Public Health Res 2 (3), 1023, 2015 | 25 | 2015 |
| Solid lipid nanoparticles regulate functional assortment of mouse mesenchymal stem cells S Chabra, M Ranjan, R Bhandari, T Kaur, M Aggrawal, V Puri, N Mahajan, ... Journal of Stem Cells & Regenerative Medicine 7 (2), 75, 2011 | 6 | 2011 |
| Identifying cancer driver genes from functional genomics screens T Togar, S Desai, R Mishra, P Terwadkar, M Ramteke, M Ranjan, D Kawle, ... Swiss Medical Weekly 150 (0708), w20195-w20195, 2020 | 5 | 2020 |
| Overview of Traditional Methods of Diagnosis and Treatment for Women-Associated Cancers M Ranjan, N Kumar, S Arfi, S Rashid Latest Advances in Diagnosis and Treatment of Women-Associated Cancers, 1-14, 2022 | | 2022 |
| Deciphering the diversity of somatic alterations and Salmonella infection in gallbladder cancer by whole exome sequencing P Iyer, SG Barreto, M Ranjan, N Gardi, S Salunkhe, B Sahoo, ... Canadian Journal of Biotechnology 1 (Special), 73, 2017 | | 2017 |
| Discovery of somatic ERBB2 mutations in human gallbladder cancer P Iyer, N Gardi, M Ranjan, P Chandrani, P Upadhyay, MR Ramadwar, ... EUROPEAN JOURNAL OF CANCER 54, S55-S55, 2016 | | 2016 |
